1 year return (CAGR)
-60.81%
NGM Biopharmaceuticals Inc Exchange (NASDAQ, USD)
NGM
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-62.09%
5 year return (CAGR)
-36.31%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
128.53M
Price/Sales
29.10
Ent value
89.95M
Price/Book
0.86
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
184.87%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 1.54 |
| Daily high | 1.54 |
| Daily low | 1.54 |
| Daily Volume | 0K |
| 1y analyst estimate | 1.66 |
| Beta | 1.26 |
| EPS (TTM) | -1.69 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NGM | S&P500 | |
| Current price drop from All-time high | -95.18% | -0.85% |
| Highest price drop | -98.12% | -56.47% |
| Date of highest drop | 17 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -46.27% | -10.68% |
| Avg time to new high | 34 days | 12 days |
| Max time to new high | 770 days | 1805 days |
News
No items found